Organon & Co | OGN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Celltrion KRW 37.87T 35.44T 2026-07
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 2.71B 1.87B 2026-07
Divis Laboratories Ltd INR 1.58T 118.27B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Glaxosmithkline GBP 108.55B 736M 2026-07
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Merck USD 297.1B 35.84B 2026-03
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Novartis USD 319.89B 31.63B 2026-07
Organigram Holdings CAD 136.51M 115.96M 2026-07
Organon & Co USD 3.47B 1.9B 2026-07
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.57B 225M 2026-03
Qiagen NV USD 8.02B 256M 2026-07
Sartorius EUR 7.63B 8B 2026-07
Zealand Pharma A/S 33.35B 448.34M 2025-12